Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events


Post IPO Valuation

General Information
DescriptionAmerican Healthcare Company


Deerfield, USA
One Baxter Parkway
Deerfield, IL, 60015


Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Show All People


Chatham Therapeutics, 4/2014 $70M
FLOWSENSE, 9/2013 $9.5M
Gambro, 9/2013 $3.9B
Prism Pharmaceuticals, 4/2011 $338M
ApaTech, 3/2010 $330M


Xenetic Biosciences 1/2014
Opsona 10/2013
Ocular Therapeutix 6/2013
Opsona 4/2013
Zytoprotec 1/2013
Naurex 12/2012
Gliknik 10/2012


Baxter International

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

The company operates through three segments: BioScience, Medication Delivery, and Renal.

  • The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines.
  • The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies.
  • The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic.

Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision.

The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Recent Milestones



Baxter International screenshot
Above: Homepage
Uploaded: 3/21/14

Stock Price


  1. Drug giant Baxter acquires Chapel Hill firm for $70M ( [edit]
  2. BRIEF: Baxter buys urine monitoring co FlowSense for $9.5m Join our daily free Newsletter ( [edit]
  3. Baxter Completes $3.9B Acquisition of Gambro ( [edit]
  4. Baxter nabs Prism's arrythmia drug in $338M buyout ( [edit]
  5. VC Exit: Baxter Acquires Synthetic Bone Graft Company ApaTech ( [edit]
  6. Xenetic gets $10M investment plus potential milestones from Baxter ( [edit]
  7. Opsona Therapeutics Raises €3M Series C Equity Financing ( [edit]
  8. Ocular Therapeutix gets $8.5M, Baxter secures minority stake ( [edit]
  9. Opsona Therapeutics Raises €33M in Series C Financing ( [edit]
  10. Zytoprotec Raises EUR 2 Million in Financing from Baxter Ventures ( [edit]
  11. Naurex Completes $38 Million Series B Financing ( [edit]
  12. Gliknik Raises $4.9M in Series B Funding ( [edit]
  13. Baxter sets up $200M venture arm for early-stage investments ( [edit]
    Baxter raising $3.5B to close Gambro megadeal ( [edit]
Edit This Page
Last Edited 4/14/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy